Human Pancreatic Ductal Adenocarcinoma Dervied Cell Line (779e)
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Pancreas |
| Organism |
Human (H. sapiens) |
| Donor History |
Moderate-to-poorly differentiated patient derived tumor |
| Growth Properties |
Adherent ,epithelial |
| Growth Conditions |
Use of PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels. PriGrow III Medium (TM003) + 10% FBS + 1X NEAA + 1X Sodium Pyruvate + 1X Glutamax + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. |
| Immortalization Method |
Tumor Cell Line |
| Full Information |
https://www.abmgood.com/Human-Pancreatic-Ductal-Adenocarcinoma-Dervied-Cell-Line-779e-t8075.html |
779e- established from a moderate-to-poorly differentiated patient derived tumor that harbored KRasG12Fmutation. 779e expresses higher E-cadherin expression and lower levels of the mesenccymal marker vimentin. Suitable for experiemental use in understaning the signaling pathways involved in PDA regulation.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
